Gupta Arun, Seth Raghav, Yadav Ajit, Kurki Vineeth
Department of Interventional Radiology, Sir Ganga Ram Hospital, New Delhi, India.
J Clin Exp Hepatol. 2025 Sep-Oct;15(5):102592. doi: 10.1016/j.jceh.2025.102592. Epub 2025 May 17.
Hepatocellular carcinoma (HCC) is the sixth most common cause of cancer worldwide and ranks third in terms of cancer related mortality. The management options for earlystage HCC include surgical resection, liver transplantation and percutaneous imageguided ablation. However, majority of the patients are not appropriate candidates for liver transplantation or surgical resection. Thus, image-guided tumour ablation has evolved as an accepted curative management option for these patients, according to most of the HCC management guidelines, due to its less invasive nature and proven efficacy. The aim of this article is to review the currently available data and the latest techniques for percutaneous ablation of HCC.
肝细胞癌（HCC）是全球第六大常见癌症病因，在癌症相关死亡率方面排名第三。早期HCC的治疗选择包括手术切除、肝移植和经皮影像引导下消融。然而，大多数患者并不适合肝移植或手术切除。因此，根据大多数HCC治疗指南，影像引导下肿瘤消融因其侵入性较小且疗效已得到证实，已成为这些患者可接受的根治性治疗选择。本文旨在综述目前可用的数据以及HCC经皮消融的最新技术。
